Testosterone Replacement Therapy and Joint Pain

Effects of TRT on Joint Pain and Musculoskeletal System

The American Urological Association guidelines do not list joint pain improvement among the expected benefits of TRT 1
TRT has not been shown to improve joint pain in clinical studies and is not recommended specifically for joint pain management 1, 2

TRT has been shown to improve bone mineral density, with increases of 7% in lumbar spine trabecular volumetric BMD after 1 year of treatment 3
Testosterone therapy can provide bone micro-architectural benefits, with significant increases in cortical volumetric BMD (3%) after 2 years 3

TRT should only be prescribed for confirmed hypogonadism with total testosterone levels below 230 ng/dL, or potentially for symptomatic men with levels between 231-346 ng/dL after careful discussion of risks and benefits 4
TRT should not be used in eugonadal men for any purpose, including joint pain management 2

Baseline and follow-up monitoring should include assessment of PSA and hematocrit/hemoglobin levels 5, 6
Baseline and follow-up monitoring should include assessment of digital rectal examination 5, 6
Baseline and follow-up monitoring should include assessment of voiding symptoms 5, 6
Baseline and follow-up monitoring should include assessment of sleep apnea history 5, 6
First follow-up should occur at 1-2 months to assess efficacy, with subsequent monitoring every 3-6 months for the first year, then annually 6

TRT is contraindicated in men trying to conceive due to effects on spermatogenesis 1, 2
TRT is contraindicated in men with active or treated breast cancer 2
TRT should be used with caution in men with severe LUTS 2

For patients with joint pain, TRT should not be prescribed solely for pain management as there is insufficient evidence supporting its efficacy for this indication 1, 2
For hypogonadal men with osteoporosis and joint pain, established anti-osteoporosis medications should be considered as the primary treatment, regardless of whether TRT is instituted 3
Lifestyle modifications, including weight loss and increased physical activity, should be recommended as first-line approaches for both hypogonadism and joint pain management 1
Target testosterone levels during therapy should be in the mid-range (350-600 ng/dL) rather than high-normal range to minimize potential adverse effects 5, 8